Hantech Bio-technology Co., Ltd. · TPEX:1294
Hantech Bio-technology — Investor Presentation (December 2025)
35 slides from Hantech Bio-technology's investor presentation, December 2025
Slide 1: Hantech Bio-Technology (1294 TT) Investor Presentation
Hantech Bio-Technology (1294 TT) Investor Presentation Taiwan’s #1 Soft-Pouch Nutritional Beverage Manufacturer & King Maker Behind Breakthrough Products Delivering End-to-End Soft-Pouch Solutions 2025/12
Slide 2: Disclaimer
Disclaimer • The information contained in this presentation, including forward-looking statements, is provided as of the date hereof and is subject to change without notice. The Company does not undertake any obligation to update or revise any information in this presentation as a result of new info
Slide 3: Summary
Summary 1. Hantech is Taiwan’s leading and largest OEM/ODM of Soft-Pouch Nutritional Beverage. Backed by an annual production capacity of 191 million pouches and a customer retention rate of 80%, Hantech drives sustainable profit growth through enhanced production efficiency and utilization rates. 2
Slide 4: 3Q25 Results & Outlook
Ss 3Q25 Results & Outlook ~ |
Slide 5: 3Q25 Consolidated Income Statement
3Q25 Consolidated Income Statement • Due to uncertainty around tariffs, customer ordering activity softened in 3Q25, leading to a slight decline in revenue to NT$196 million (-1.4% YoY). Operating profit was NT$38 million (-30.1% YoY) in 3Q25. However, customer orders resumed in September, with mont
Slide 6: 9M25 Consolidated Income Statement
9M25 Consolidated Income Statement • For 9M25, revenue reached NT$565 million (-5.1% YoY), operating profit was NT$127 million (-21.3% YoY), and EPS was NT$3.37 (-24.9% YoY). 9M25 9M24 YOY (NT$ Million) Amount Amount % Revenue 565 595 -5.1% Gross Profit 208 245 -15.0% Operating Expenses (81) (84) -3
Slide 7: 3Q25 Consolidated Balance Sheet
3Q25 Consolidated Balance Sheet 3Q25 3Q24 (NT$ Million) YoY (%) Amount % Amount % Cash 216 20 404 34 (46.4) Accounts Receivable & Notes Receivable 109 10 99 8 9.2 Inventory 88 8 76 6 14.1 Other Current Assets 99 9 26 3 281.5 Long-term Investments 1 0 1 0 0.0 Property, Plant and Equipment (PPE) 544 5
Slide 8: 4Q25 & 2026 Outlook
4Q25 & 2026 Outlook 4Q25：Recovery from the trough, revenue expected to return to YoY growth • As tariff-related uncertainties gradually ease, customer orders have normalized. Revenue grew 39.8% YoY in September and 43.7% in October, signaling a renewed growth trajectory likely to extend through 4Q25
Slide 9: Company Overview
Ss Company Overview ~
Slide 10: Hantech: Taiwan's Largest Pouch Functional Beverage Manufacturer
Hantech: Taiwan’s Largest Pouch Functional Beverage Manufacturer Product Mix Sales Breakdown 2007 Established Employees 4% 2% 170 employees (2025/10) Production Sites 2 facilities (Changhua, Taiwan) Annual Capacity 191 million pouches (Largest in Taiwan) Sales Volume 96% 98% > 80 million units (2024
Slide 11: Key Milestones
Key Milestones 2007 • Hantech officially established as a processing facility • Installed liquid horizontal sterilization and soft pouch filling equipment 2012 • Obtained ISO 22000 and HACCP certifications • Established Yuanlin Zhongshan Plant 2015 • Deer Antler Extract, Collagen, and Pearl Powder p
Slide 12: Key Milestones
Key Milestones • Established subsidiary: Han Chih Technology Co., Ltd. • Approved by the Invest Taiwan in Ministry of Economic Affairs for NT$577 million under the “SME Accelerated Investment 2020 Program” to established Xihu Headquarters Plant • Acquired land in Xihu Industrial Park to build an int
Slide 13: Product Coverage Across All Age Groups; Key Functions & 4 Sales Channels
Product Coverage Across All Age Groups； 12 Key Functions & 14 Sales Channels Intimate Fat & Sugar Antioxidant Care Control Digestive & Skin Support Beauty Immunity Liver Boost Protection Stress Skin & Body Relief & Protection Sleep Aid Muscle Vision Adults & Support Strength Support Bone & Promote J
Slide 14: From Market Insights to Commercial Hits: Building Star Products
From Market Insights to Commercial Hits: Building Star Products Through Data and Integrated Innovation Achieved a 30% success rate with over 3 million units of star products sold, establishing our role as a King Maker in the market. ① ④ ② ③ Market Go-to-Market R&D Innovation Packaging Design Intelli
Slide 15: King Maker Success Case – Client L
King Maker Success Case – Client L From Market Insight to Million-Unit Bestseller: Demonstrating Hantech’s Full-Stack Execution Opportunity Identification Technology Breakthrough Market Impact & Stable Production •Hantech identified overseas trends in • White fungus is known for its beauty • The pro
Slide 16: Customer Retention Nears 80% — A Stable Customer Base
Customer Retention Nears 80% — A Stable Customer Base A solid customer base is the foundation for continued expansion Accumulation of Existing and New Customers Builds Steady Major Brands Contribute Consistently, Strong Order Stickiness (units) Pipeline Momentum 100% 140 7% 90% 19% 18% 120 80% 35% 4
Slide 17: Accumulated Existing and New Customers Drive Steady Revenue Growth
Accumulated Existing and New Customers Drive Steady Revenue Growth Existing customers provide a stable revenue base, while new customers bring incremental growth Steady Customer Contributions + Continuous New Customer (NT$ million) Onboarding Accelerate Hantech's Revenue Growth Solid Foundation (Exi
Slide 18: Scale Drives Efficiency, Efficiency Multiplies Profitability
Scale Drives Efficiency, Efficiency Multiplies Profitability Scale × Efficiency = A Profitable and Sustainable Operating Model Capacity expansion drives growth, margin improvement, and sustained high ROE. Hantech Revenue, Operating Margin, and ROE (NT$ million) (million) 2021 2022 2023 2024 2,000 60
Slide 19: Industry Overview
Ss Industry Overview ~
Slide 20: 24/7 Deep Engagement to Build Always-On Consumer Intimacy
24/7 Deep Engagement to Build Always-On Consumer Intimacy
Slide 21: Pouch Packaging Offers Clear Cost and Efficiency Advantages, Driving Transition
Pouch Packaging Offers Clear Cost and Efficiency Advantages, Driving Transition Pouch packaging helps brands improve cost, profitability, ESG performance, and logistics efficiency, accelerating the shift from glass bottles to pouches. Higher Consumption Rate Consumption rate is several times higher
Slide 22: Pouches is a New, Tasty, and Convenient Option for Daily Nutritional Supplementation
Pouches is a New, Tasty, and Convenient Option for Daily Nutritional Supplementation Liquid/jelly forms are gradually replacing tablets and capsules, turning health supplements into part of a daily, effortless drinking habit. High Absorption Rate Small molecules / micronization technology → Quick an
Slide 23: Soft-Pouch Nutritional Beverage Have Low Market Penetration in Taiwan
Soft-Pouch Nutritional Beverage Have Low Market Penetration in Taiwan — Growth Potential Remains Significant Taiwan Dietary Supplement Market Size (NT$100 million) • According to ITIS, Taiwan's dietary 2,000 1,801 NT$180.1 supplement market is projected to reach NT$180.1B in 2024, 1,500 Billion main
Slide 24: Strategy and Goal
Ss Strategy and Goal ~
Slide 25: Hantech's Three Growth Strategy Driving Continuous Breakthroughs
Hantech’s Three Growth Strategy Driving Continuous Breakthroughs Expanding across multiple platforms to continue empowering Hantech as a King Maker Amplify Advantages Activate Hantech’s A cc international growth engine elerate Global Expansio n Broaden customer reach and Deepen Channel Penetration m
Slide 26: Strategic Alliances + Innovative Ingredients: Incubation of Billion Markets
Strategic Alliances + Innovative Ingredients: Incubation of Billion Markets Hantech turns each high-potential ingredient into the next growth engine through innovation and strategic alliances 2024 Taiwan Dietary Supplement Market Breakdown (Unit: NT$) ① Each Ingredient Holds Billion-NTD Market Oppor
Slide 27: Strengthen Channel Penetration and Expand Customer Reach
Strengthen Channel Penetration and Expand Customer Reach Deepen presence in previously under-penetrated channels such as direct selling, pharmacies, and supermarkets High Penetration Medium Penetration Low Penetration Convenience E-commerce Stores Marketplaces Owned Retail Micro- Aesthetic Stores co
Slide 28: Accelerate Global Expansion and Drive the International Growth Engine
Accelerate Global Expansion and Drive the International Growth Engine Advance overseas growth through existing-customer expansion and new-client development ① Overseas Market Opportunities • Southeast Asia Demand Rising Rapidly: Expanded into Hong Kong, Malaysia, and Singapore, and continues securin
Slide 29: Hantech's Five-Year Strategic Goals
Hantech’s Five-Year Strategic Goals Centered on high ROE and stable cash flow, building Asia’s leading Soft-Pouch Nutritional Beverage manufacturer Become the leading Deliver industry- manufacturer of leading revenue Maintain strong free Soft-Pouch growth consistently cash flow and a Nutritional div
Slide 30: THANK YOU
THANK YOU 30 https://www.htbios.com/
Slide 31: Sustainability
Sustainability 31
Slide 32: Sustainable Management: Driving Efficiency and Trust Through Responsibility
Sustainable Management: Driving Efficiency and Trust Through Responsibility ENVIRONMENT SOCIAL GOVERNANCE • Carbon Management：Completed • Food Safety Management: • Board Diversity：The board consists of Scope 1 and 2 carbon inventory in 2024 0 food safety incidents in 2024. 9 directors, including 4 i
Slide 33: Financial Statements
Ss Financial Statements ~ .
Slide 34: Consolidated Income Statement – Past Five Years
Consolidated Income Statement – Past Five Years YoY (Note 2) NT$ million 2020 2021 2022 2023 2024 9M25 2020 2021 2022 2023 2024 9M25 Revenue 267 240 302 625 748 565 130.2 -9.9 25.9 106.6 19.7 0.6 Gross Profit 126 101 126 281 305 208 180.4 -20.0 25.3 121.8 8.9 -9.1 Operating Expenses 53 62 69 95 108
Slide 35: Consolidated Balance Sheet – Past Five Years
Consolidated Balance Sheet – Past Five Years YoY NT$ million 2020 2021 2022 2023 2024 9M25 2020 2021 2022 2023 2024 9M25 Total Assets 310 376 474 931 1,119 1,091 147.2 21.1 26.1 96.6 20.2 -2.5 Cash and Cash Equivalents 82 86 75 167 382 216 305.5 5.7 -13.2 122.7 128.9 -43.5 Accounts Receivable and No
Hantech Bio-Technology — Investor Presentation (December 2025) on 6ix